809 results on '"Severens, Johan L"'
Search Results
2. Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report
3. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management
4. Health care input constraints and cost effectiveness analysis decision rules
5. TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility
6. Impact of hospitalisation on health-related quality of life in patients with chronic heart failure
7. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom
8. Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia
9. Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal
10. The Effect of Presenting Information about Invasive Follow-Up Testing on Individuals’ Noninvasive Colorectal Cancer Screening Participation Decision: Results from a Discrete Choice Experiment
11. Diagnosing Alzheimer's disease: A systematic review of economic evaluations
12. Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
13. A review of economic evaluations of behavior change interventions: setting an agenda for research methods and practice
14. Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”
15. Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from Celgene
16. Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine
17. The Cloudy Crystal Ball of Cost-Effectiveness Studies
18. Patients’ preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists
19. Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects
20. Exploring non-health outcomes of health promotion: The perspective of participants in a lifestyle behaviour change intervention
21. Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies: Influence of Differences in Modeling Methods on Outcomes
22. Development of a Composite Questionnaire, the Valuation of Lost Productivity, to Value Productivity Losses: Application in Rheumatoid Arthritis
23. Health-related quality of life after fast-track treatment results from a randomized controlled clinical equivalence trial
24. Modeling the Value for Money of Changing Clinical Practice Change: A Stochastic Application in Diabetes Care
25. Considered judgement in evidence-based guideline development
26. Exposure to Tuberculosis among Newborns in a Nursery: Decision Analysis for Initiation of Prophylaxis
27. Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis
28. Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease
29. The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance
30. Consumer willingness to invest money and time for benefits of lifestyle behaviour change: an application of the contingent valuation method
31. What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?
32. The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines
33. Modeling Complex Treatment Strategies: Construction and Validation of a Discrete Event Simulation Model for Glaucoma
34. Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands
35. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons
36. The Transferability of Economic Evaluations: Testing the Model of Welte
37. More is not always better: Cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain
38. Acknowledging Patient Heterogeneity in Economic Evaluation: A Systematic Literature Review
39. Lost Productivity in Four European Countries among Patients with Rheumatic Disorders: Are Absenteeism and Presenteeism Transferable?
40. Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands
41. Observational studies: a valuable source for data on the true value of RA therapies
42. The burden of illness of rheumatoid arthritis
43. Difficulties in Calculating Productivity Costs: Work Disability Associated with Borderline Personality Disorder
44. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study
45. The long term effectiveness and cost-effectiveness of initiating treatment for ocular hypertension
46. Cost–effectiveness of risk assessment and tailored treatment for peripheral arterial disease patients
47. Utilities of the EQ-5D: Transferable or Not?
48. How to Deal with Cost Differences at Baseline
49. Economic evaluation of an integrated diagnostic approach for psychogeriatric patients: results of a randomized controlled trial
50. Clinical impact of the use of additional ultrasonography in diagnostic breast imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.